Patent ID: 9161565
Filing Date: 2015-10-20
Classification: A23L,A23V,A61K,A61Q

Abstract:
1. A formulation comprising at least 20 of the following supplemental components: i. Dihydroepiandrosterone at about 100 mg; ii. Pregnenolone at about 60 mg; iii. Zinc citrate at about 60 mg; iv. Diindolylmethane at about 200 mg; v. Chrysin at about 1500 mg; vi. Resveratrol at about 250 mg; vii. Quercetin at about 150 mg; viii. Saw palmetto at about 320 mg; ix. Finasteride at about 2.5 mg; x. Fenugreek at about 90 mg; xi. Vitamin C at about 1,000 mg; xii. Stinging nettle at about 240 mg; xiii. Boron at about 3 mg; xiv. Norway spruce lignan extract at about 50 mg; xv. Ginger root at about 100 mg; xvi. Yohimbine at about 20 mg; xvii. Tribulus terrestris at about 300 mg; xviii. Eurycoma longifolia at about 50 mg; xix. Muira puama at about 850 mg; xx. Maca at about 320 mg; xxi. Bioperine at about 7.5 mg; xxii. Cernilton at about 250 mg; xxiii. Pumpkin seed oil at about 200 mg; xxiv. Pygeum africanum at about 100 mg; xxv. Lycopene at about 50 mg; xxvi. Mucuna pruriens at about 300 mg; xxvii. Red clover flower extract at about 50 mg; xxviii. Ginkgo biloba at about 60 mg; xxix. Korean ginseng at about 50 mg; xxx. Grape seed extract at about 300 mg; xxxi. Panax ginseng at about 100 mg; xxxii. Ashwagandha at about 300 mg; xxxiii. Epimedium brevicornum herb; xxxiv. Selenium at about 100 mcg; and xxxv. Beta sitosterol at about 100 mg; wherein the formulation is effective for improving wellness of a human male patient.